tiprankstipranks
Advertisement
Advertisement
Cipla USA Recalls Lanreotide Injection, Causing Temporary Supply Disruption
PremiumCompany AnnouncementsCipla USA Recalls Lanreotide Injection, Causing Temporary Supply Disruption
2M ago
Cipla Seeks Shareholder Nod for New Global CEO and Board Changes via Postal Ballot
Premium
Company Announcements
Cipla Seeks Shareholder Nod for New Global CEO and Board Changes via Postal Ballot
2M ago
Cipla Says Maharashtra GST Inspection Concludes With No Material Impact
Premium
Company Announcements
Cipla Says Maharashtra GST Inspection Concludes With No Material Impact
3M ago
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
PremiumMarket NewsLilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
4M ago
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
Premium
Company Announcements
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
5M ago
Cipla Ltd Completes Acquisition of Inzpera Healthsciences
Premium
Company Announcements
Cipla Ltd Completes Acquisition of Inzpera Healthsciences
5M ago
Cipla Opens Special Window for Physical Share Transfers
PremiumCompany AnnouncementsCipla Opens Special Window for Physical Share Transfers
9M ago
Cipla Ltd Announces Strong Q1 2025 Financial Results
Premium
Company Announcements
Cipla Ltd Announces Strong Q1 2025 Financial Results
9M ago
Eli Lilly and Cipla’s Diabetes Study: A Potential Game-Changer for Type 2 Diabetes Management
Premium
Company Announcements
Eli Lilly and Cipla’s Diabetes Study: A Potential Game-Changer for Type 2 Diabetes Management
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100